PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1629307
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1629307
Angiography Equipment Market size was valued at US$ 13,094.2 Million in 2024, expanding at a CAGR of 5.20% from 2025 to 2032.
Angiography equipment is essentially medical imaging equipment used to see an individual's internal organs and to evaluate blood vessels and their flow in arteries, veins, and heart chambers. In arteries, veins, and heart chambers, it is typically used to examine blood vessels and their flow. A radio-opaque contrast agent is injected in the patient's bloodstream to do this, and X-ray-based methods-most notably X-ray fluoroscopy-are used to create the image. The major reason propelling the growth of the angiography equipment market during the aforementioned projected period is the ageing population, the rise of coronary vascular disorders, and the rising incidence of cardiovascular illnesses worldwide. Furthermore, factors like financing initiatives, conferences, and awareness campaigns, as well as the need for interventional angiography systems in minimally invasive operations, are driving the market's overall expansion. The market's overall expansion is also anticipated to be accelerated by the growing demand for minimally invasive operations as well as advantageous government programs and reimbursement practices in developed nations.
Angiography Equipment Market- Market Dynamics
Growing use of minimally invasive procedures
The increased emphasis on patient-centred care and the need for therapies that put patient comfort and safety first are two major factors driving the growing use of minimally invasive procedures. With fewer incisions, less tissue damage, and less disturbance to nearby tissues, minimally invasive procedures like angioplasty and stent implantation enable the correction of arterial anomalies. Patients having angiography treatments benefit from shorter hospital stays, quicker recovery periods, and better functional outcomes after surgery. The development of minimally invasive procedures has been made possible in large part by advancements in angiography equipment technology. Accurate catheter navigation and therapeutic intervention delivery are made possible by high-resolution imaging modalities, including X-ray angiography, CT angiography, and MRA, which give physicians precise anatomical information and real-time vision of blood arteries. Furthermore, the creation of specific balloons, guidewires, and catheters for minimally invasive treatments has improved patient safety and procedural success rates. Economic considerations are also driving the trend toward minimally invasive operations, which have the potential to save healthcare systems money by lowering inpatient expenses, operating room stays, and postoperative problems as compared to open surgeries.
Angiography Equipment Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.20% over the forecast period (2025-2032)
Based on technology segmentation, the X-ray was predicted to show maximum market share in the year 2024
Based on application segmentation, diagnostic were the leading category in 2024
Based on procedure segmentation, coronary were the leading category in 2024
On the basis of region, North America was the leading revenue generator in 2024
The Global Angiography Equipment Market is segmented on the basis of Technology, Product, Application, Procedure, and Region.
On the basis of technology, the market is segregated into X-Ray, CT, and MRA. The industry for angiography equipment was dominated by X-ray. The market is divided into three technological segments: CT, MRA, and X-ray. Businesses are spending a lot of money creating new technology, which should help the industry expand. The market is anticipated to be driven by the need to reduce radiation dose, increase picture quality, and follow new trends in cath labs. With the introduction of the new neuro biplane system in February 2024, Koninklijke Philips N.V. announced improvements to its Azurion Image Guided Therapy System. This device is designed to enhance neurovascular treatments, allowing for better results, more patient therapy, and quicker decision-making. It has variable X-ray detector locations and sophisticated 2D and 3D imaging.
Based on application, the market is divided into Therapeutic and Diagnostic. In 2024, the diagnostic category held a dominant market share. Cerebral aneurysms, acute stroke, brain arteriovenous malformation, dural arteriovenous fistula, suspected cerebral vasculitis and occlusive disorders are among the conditions for which developments in CTA and MRA provide pertinent information in cardiology and neurology. The market is anticipated to rise as a result of increased knowledge of cardiovascular diseases (CVDs) and the risk factors associated with them. Siemens Healthineers announced in March 2024 that the FDA had approved the CIARTIC Move, a mobile C-arm with autonomous driving capabilities.
Angiography Equipment Market- Geographical Insights
With a 37.0% market share in 2024, North America dominated the angiography equipment market because of its sophisticated healthcare system, high healthcare costs, and plenty of top pharmaceutical and medical device manufacturers. Growth is also fueled by the region's high rate of adoption of cutting-edge medical technologies and concentration on research and development. A new expert consensus statement on STEMI care for primary PCI was published in JSCAI in October 2024 by the Society for Cardiovascular Angiography and Interventions (SCAI). With regard to complicated clinical situations such as high thrombus burden and no-reflow occurrences, the statement offers doctors helpful advice. In addition to recommending sophisticated imaging equipment and mechanical support for difficult situations, it highlights the necessity of particular equipment in cardiac catheterization labs.
The angiography equipment market in Asia Pacific is anticipated to grow rapidly during the forecast period. The healthcare industry is expanding quickly in Asia-Pacific due to the region's sizable and diverse population, advancing healthcare infrastructure, and rising healthcare costs. The expansion of the middle class, the rise in chronic illnesses, and government programs to increase access to healthcare all support the expansion of the medical market, especially in nations like China, Japan, and India. The National University Heart Centre, Singapore (NUHCS) Angiography Centre reopened in November 2024 with a redesigned lobby area that has additional seating. Modern diagnostic and imaging technology, as well as a larger area for patient recovery are aspects of the renovated facility.
A few of the major companies in the angiography equipment market are General Electric Company, Koninklijke Philips N.V., Siemens Healthineers AG, Canon Corporation, Boston Scientific Corporation, and others. By investing heavily in infrastructure, these corporations are able to develop, produce, and market a large number of medications globally. Companies also form a number of strategic alliances with distributors and other businesses in order to expand their global footprint. For instance, in order to increase productivity and lessen the strain on medical personnel, Shimadzu Corporation introduced SMART Voice, a voice recognition function for its Trinias angiography equipment, in October 2024. At future events in Kobe, Washington, D.C., and the RSNA exhibition in Chicago, the technology will be showcased, improving catheterization operations without taking focus away from the affected area.
Recent Development
June 2024: Optical Coherence Tomography (OCT) of the Glauvas was introduced by NIDEK CO., LTD. With its 250 kHz scanning speed, this state-of-the-art technology allows for quick and precise imaging. With regard to glaucoma and retinal vascular disorders, it is intended to improve workflow effectiveness and diagnostic confidence. It provides enhanced chorioretinal microvasculature evaluation with advanced AngioScan OCT-Angiography and enhanced clarity in B-scan imaging.
February 2024: The Philips CT 5300 system, which comes with state-of-the-art AI technology for screening, interventional procedures, and diagnostics, was introduced by Koninklijke Philips N.V. Patient outcomes are eventually improved by this adaptable X-ray CT system's increased diagnostic accuracy, increased workflow efficiency, and optimized equipment availability. Throughout #ECR2024, Philips collaborates with healthcare providers to boost efficiency and advance more environmentally friendly medical solutions.
April 2023: Caristo Diagnostics Limited, a world leader in the diagnosis and risk assessment of heart and vascular diseases, raised an extra USD 16.3 million to close off its Series A fundraising round. Using the money, Caristo intends to advance its CaRi-Heart technology, a risk assessment tool, and AI-assisted diagnostics in order to establish itself as the industry standard for cardiac care in important global markets. CaRi-Heart's AI algorithms, which make use of Caristo's Fat Attenuation Index (FAI) technology, enable skilled medical professionals to derive coronary inflammatory values from routine cardiac computed tomography angiography (CCTA).